Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2026-01-05 @ 5:56 PM
Study NCT ID:
NCT05360368
Status:
UNKNOWN
Last Update Posted:
2022-05-05
First Post:
2022-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors
Sponsor:
Shanghai Henlius Biotech
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HLX07-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None